Intravenous Tissue Plasminogen Activator as Provocateur of Myocardial Infarction

被引：2
|
作者：
Burlen, Jordan [1 ]
Cholin, Liza [1 ]
Ruzieh, Mohammed [2 ]
Dasa, Osama [2 ]
机构：
[1] Univ Louisville, Sch Med, Dept Internal Med, Louisville, KY 40292 USA
[2] Univ Toledo, Coll Med, Dept Internal Med, 2801 W Bancroft St, Toledo, OH 43606 USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2017年 / 24卷 / 04期
关键词：
ISCHEMIC-STROKE; THERAPY;
D O I：
10.1097/MJT.0000000000000494
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E489 / E490
页数：2
相关论文
共 50 条
  • [1] Tissue plasminogen activator in pediatric myocardial infarction
    Krendel, S
    Pollack, P
    Hanly, J
    ANNALS OF EMERGENCY MEDICINE, 2000, 35 (05) : 502 - 505
  • [2] Role of tissue plasminogen activator and plasminogen activator inhibitor polymorphism in myocardial infarction
    Waqas Ahmed
    Meera Malik
    Imran Saeed
    Amina Ali Khan
    Ahmed Sadeque
    Umar Kaleem
    Nuzhat Ahmed
    Muhammad Ajmal
    Maleeha Azam
    Raheel Qamar
    Molecular Biology Reports, 2011, 38 : 2541 - 2548
  • [3] Role of tissue plasminogen activator and plasminogen activator inhibitor polymorphism in myocardial infarction
    Ahmed, Waqas
    Malik, Meera
    Saeed, Imran
    Khan, Amina Ali
    Sadeque, Ahmed
    Kaleem, Umar
    Ahmed, Nuzhat
    Ajmal, Muhammad
    Azam, Maleeha
    Qamar, Raheel
    MOLECULAR BIOLOGY REPORTS, 2011, 38 (04) : 2541 - 2548
  • [4] An ischemic stroke during intravenous recombinant tissue plasminogen activator infusion for evolving myocardial infarction
    Chang, GYN
    EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (03) : 267 - 268
  • [5] Effects of intravenous administration of tissue plasminogen activator before thrombectomy in patients with acute myocardial infarction
    Yamamoto, S
    Kamihata, H
    Sutani, Y
    Akita, Y
    Otani, H
    Iwasaka, T
    CIRCULATION JOURNAL, 2006, 70 (03) : 243 - 247
  • [6] A Myocardial Infarction During Intravenous Recombinant Tissue Plasminogen Activator Infusion for Evolving Ischemic Stroke
    Fitzek, Sabine
    Fitzek, Clemens
    NEUROLOGIST, 2015, 20 (03) : 46 - 47
  • [7] Tissue plasminogen activator and risk of myocardial infarction - The Rotterdam study
    vanderBom, JG
    deKnijff, P
    Haverkate, F
    Bots, ML
    Meijer, P
    deJong, PTVM
    Hofman, A
    Kluft, C
    Grobbee, DE
    CIRCULATION, 1997, 95 (12) : 2623 - 2627
  • [8] A RANDOMIZED CONTROLLED TRIAL OF INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND EARLY INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
    TOPOL, EJ
    GEORGE, BS
    KEREIAKES, DJ
    STUMP, DC
    CANDELA, RJ
    ABBOTTSMITH, CW
    ARONSON, L
    PICKEL, A
    BOSWICK, JM
    LEE, KL
    ELLIS, SG
    CALIFF, RM
    CIRCULATION, 1989, 79 (02) : 281 - 286
  • [9] A COMPARISON BETWEEN INTRAVENOUS STREPTOKINASE AND TISSUE PLASMINOGEN-ACTIVATOR WITH EARLY INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
    CHERNG, WJ
    CHIANG, CW
    KUO, CT
    LEE, CP
    LEE, YS
    AMERICAN HEART JOURNAL, 1992, 123 (04) : 841 - 846
  • [10] Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients With Recent Myocardial Infarction.
    Inohara, Taku
    Liang, Li
    Kosinski, Andrzej
    Smith, Eric E.
    Schwamm, Lee H.
    Hernandez, Adrian F.
    Bhatt, Deepak L.
    Fonarow, Gregg C.
    Peterson, Eric D.
    Xian, Ying
    STROKE, 2019, 50
12345